Literature DB >> 24139800

mTORC1 targets the translational repressor 4E-BP2, but not S6 kinase 1/2, to regulate neural stem cell self-renewal in vivo.

Nathaniel W Hartman1, Tiffany V Lin, Longbo Zhang, Grace E Paquelet, David M Feliciano, Angélique Bordey.   

Abstract

The mammalian target of rapamycin complex 1 (mTORC1) integrates signals important for cell growth, and its dysregulation in neural stem cells (NSCs) is implicated in several neurological disorders associated with abnormal neurogenesis and brain size. However, the function of mTORC1 on NSC self-renewal and the downstream regulatory mechanisms are ill defined. Here, we found that genetically decreasing mTORC1 activity in neonatal NSCs prevented their differentiation, resulting in reduced lineage expansion and aborted neuron production. Constitutive activation of the translational repressor 4E-BP1, which blocked cap-dependent translation, had similar effects and prevented hyperactive mTORC1 induction of NSC differentiation and promoted self-renewal. Although 4E-BP2 knockdown promoted NSC differentiation, p70 S6 kinase 1 and 2 (S6K1/S6K2) knockdown did not affect NSC differentiation but reduced NSC soma size and prevented hyperactive mTORC1-induced increase in soma size. These data demonstrate a crucial role of mTORC1 and 4E-BP for switching on and off cap-dependent translation in NSC differentiation.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24139800     DOI: 10.1016/j.celrep.2013.09.017

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  62 in total

1.  Activating the translational repressor 4E-BP or reducing S6K-GSK3β activity prevents accelerated axon growth induced by hyperactive mTOR in vivo.

Authors:  Xuan Gong; Longbo Zhang; Tianxiang Huang; Tiffany V Lin; Laura Miyares; John Wen; Lawrence Hsieh; Angélique Bordey
Journal:  Hum Mol Genet       Date:  2015-07-28       Impact factor: 6.150

Review 2.  Stem cell guidance through the mechanistic target of rapamycin.

Authors:  Kenneth Maiese
Journal:  World J Stem Cells       Date:  2015-08-26       Impact factor: 5.326

3.  Widespread Translational Remodeling during Human Neuronal Differentiation.

Authors:  John D Blair; Dirk Hockemeyer; Jennifer A Doudna; Helen S Bateup; Stephen N Floor
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

4.  Hypervascularization in mTOR-dependent focal and global cortical malformations displays differential rapamycin sensitivity.

Authors:  Longbo Zhang; Tianxiang Huang; Shannon Teaw; Angélique Bordey
Journal:  Epilepsia       Date:  2019-05-24       Impact factor: 5.864

Review 5.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

6.  Control of embryonic stem cell self-renewal and differentiation via coordinated alternative splicing and translation of YY2.

Authors:  Soroush Tahmasebi; Seyed Mehdi Jafarnejad; Ingrid S Tam; Thomas Gonatopoulos-Pournatzis; Edna Matta-Camacho; Yoshinori Tsukumo; Akiko Yanagiya; Wencheng Li; Yaser Atlasi; Maxime Caron; Ulrich Braunschweig; Dana Pearl; Arkady Khoutorsky; Christos G Gkogkas; Robert Nadon; Guillaume Bourque; Xiang-Jiao Yang; Bin Tian; Hendrik G Stunnenberg; Yojiro Yamanaka; Benjamin J Blencowe; Vincent Giguère; Nahum Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

7.  Single-cell RNA-seq analysis revealed long-lasting adverse effects of tamoxifen on neurogenesis in prenatal and adult brains.

Authors:  Chia-Ming Lee; Liqiang Zhou; Jiping Liu; Jiayu Shi; Yanan Geng; Min Liu; Jiaruo Wang; Xinjie Su; Nicholas Barad; Junbang Wang; Yi Eve Sun; Quan Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-29       Impact factor: 11.205

Review 8.  A liaison between mTOR signaling, ribosome biogenesis and cancer.

Authors:  Antonio Gentilella; Sara C Kozma; George Thomas
Journal:  Biochim Biophys Acta       Date:  2015-02-28

9.  The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer's Disease, Based on a Mechanistic Target of Rapamycin Pathway.

Authors:  Lin Li
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

10.  Neural progenitors derived from Tuberous Sclerosis Complex patients exhibit attenuated PI3K/AKT signaling and delayed neuronal differentiation.

Authors:  Avery J Zucco; Valentina Dal Pozzo; Alina Afinogenova; Ronald P Hart; Orrin Devinsky; Gabriella D'Arcangelo
Journal:  Mol Cell Neurosci       Date:  2018-08-23       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.